WallStSmart
RMTI

Rockwell Medical Inc

NASDAQ: RMTI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$0.84
+3.21% today

Updated 2026-06-04

Market cap
$27.08M
P/E ratio
P/S ratio
0.40x
EPS (TTM)
$-0.15
Dividend yield
52W range
$1 – $2
Volume
0.3M

Rockwell Medical Inc (RMTI) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item
Total assets
Cash & equivalents
Current assets
Total liabilities
Current liabilities
Long-term debt
Shareholder equity
Retained earnings
Accounts receivable
Inventory
Goodwill

Frequently asked questions

What is Rockwell Medical Inc's revenue?

Rockwell Medical Inc's trailing twelve-month revenue is $67.68M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is RMTI?

In its most recent fiscal year, RMTI ran a gross margin of 16.89%, an operating margin of -6.77%, and a net margin of -7.67%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does RMTI generate?

RMTI produced $-1.20M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.